Image of the Day: Right on Target
Image of the Day: Right on Target
An injectable biomaterial calls cancer drugs to tumor sites in mice.
Image of the Day: Right on Target
Image of the Day: Right on Target

An injectable biomaterial calls cancer drugs to tumor sites in mice.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

pharma & biotech
Smart Pills Help Monitor Cancer Patients’ Therapy
Smart Pills Help Monitor Cancer Patients’ Therapy
Chia-Yi Hou | Jul 15, 2019
Sensors encapsulated with oral chemotherapy drugs help patients and physicians keep track of treatments.
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Biotechs Race to Develop Stem Cell Treatments for Diabetes
Eric Bender | Jul 15, 2019
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
MyHeritage Launches Health-Related Genetic Test, Ignites Debate
Catherine Offord | Jul 9, 2019
Its screen for selected variants of some disease-linked genes gives customers an incomplete picture of their risk—do they know?
Chemist Behind the Combined Oral Contraceptive Dies at 102
Chemist Behind the Combined Oral Contraceptive Dies at 102
Catherine Offord | Jul 2, 2019
George Rosenkranz was part of a team in Mexico City that first synthesized norethindrone in 1951.

Genetically Modified Wheat Found in a Field in Washington State
Genetically Modified Wheat Found in a Field in Washington State
Catherine Offord | Jun 9, 2019
The unapproved crop is resistant to glyphosate in the weedkiller Roundup, but doesn’t seem to have entered the food supply.
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
MIT Researcher Allegedly Copied Other Groups’ Drug Designs
Catherine Offord | May 29, 2019
Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.
FDA Approves Gene Therapy for Spinal Muscular Atrophy
FDA Approves Gene Therapy for Spinal Muscular Atrophy
Ashley Yeager | May 27, 2019
At $2 million for a single dose, Novartis’s Zolgensma is the most expensive medicine to date, but still less expensive over a lifetime than another approved drug for the rare genetic disease.
Clinical Trial Underway for a Natural Killer Cell Therapy
Clinical Trial Underway for a Natural Killer Cell Therapy
Chia-Yi Hou | May 7, 2019
The cells, derived from induced pluripotent stem cells, are in testing as an immunotherapy for cancer patients with solid tumors.
Artificial Intelligence Shakes Up Drug Discovery
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
欧洲杯竞猜